Your search matched 57 results
The Syneos Health Podcast, Coronavirus Special Edition: The Personal Experience | Perspectives
The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.
The Syneos Health Podcast, Coronavirus Special Edition: Payers and COVID-19 | Perspectives
In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic.
How Health Tech is Helping Countries Around the World Tackle Coronavirus | Blog
With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.
The Syneos Health Podcast, Coronavirus Special Edition: The Leader's Experience | Perspectives
In this episode of our Coronavirus Special Edition Series, Syneos Health CEO Alistair Macdonald discusses the unique decisions to be made as a pharmaceutical organization practicing corporate responsibility in the name of public health.
The Syneos Health Podcast, Coronavirus Special Edition: Telemedicine in the Age of COVID-19 | Perspectives
In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.
Fors Marsh Group Selected by HHS to Build $250 Million Public Coronavirus Campaign | Blog
The Department of Health and Human Services (HHS) has selected the Fors Marsh Group to handle the new $250 million coronavirus campaign.
The Syneos Health Podcast, Coronavirus Special Edition: COVID-19 and Children | Perspectives
Over the course of the COVID-19 pandemic, information has varied around whether or not – and how severely – children are affected by the virus.
Israel Gets Head Start in Race for COVID-19 Vaccine | Blog
For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.
As Moods Shift Around COVID, Pharma Makes New Social Plans | Blog
One major development is the drop in number of social-media conversations about coronavirus.
COVID vaccine deemed essential to re-opening activities—But, no-thanks, it’s not for me! | Blog
With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.
Could Coronavirus Re-shape Learning and Development in Pharma? | In The Media
An insightful PMLive article by Yvonne Ash (VP Learning Solutions) focusing on the evolving role of learning and development, and how to prepare for a new digital age in pharma.
Novo Nordisk Tailors Launch for COVID-era Customers | Blog
Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.
Here are a Few Changes We Can Expect to See in Our World After COVID | Blog
COVID-19 has accelerated the rate at which we’re seeing change happening around us.
Is Your Mask Up to the Task? | Blog
Deciding when, where, and what mask to wear has been a large topic of discussion as we re-enter into the “New Normal.”
P2P Networks Huge for COVID-19 Patients, Responders | Blog
Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.
Biden Supports Waiving IP Protections for COVID-19 Vaccines. | Blog
As you may have read, the Biden administration announced last week that it will support a proposal to temporarily waive certain intellectual property (IP) protections for COVID-19 vaccines and therapies.
Engaging Media During Unprecedented Times: Insights for Your Business From a National Press Survey | Perspectives
To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.
Impacts of Telemedicine on Patient Engagement During COVID-19 | Blog
Understanding the impact that telemedicine has had on HCP behaviors including prescribing in the changing COVID-19 landscape.
Trends Update: Healthcare In the 2020 That No One Saw Coming | Perspectives
Our 10th annual trends report came out just over six months ago— in what may now feel like a distant world.
Masks & Sharks: What Are Your Plans for July 4th, 2020 | Blog
The way we think about and celebrate summer has dramatically changed since this time last year.
Why Hospitals Really Like the Changes They Made for COVID-19 | Blog
As the pandemic surged, New York City’s Mt.
PHARMA TRENDS 2020—2025: Four Headwinds Driving Healthcare Transformation — and What We’re Doing | Blog
How COVID-19 and 3 other barriers will transform healthcare over the next few years.
What to Expect From Contact Tracing in Our Next Phase of COVID-19 | Blog
You might want to think twice about ignoring that call from a random number.
Big Pharma Fund Fights Menacing Superbugs | Blog
COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050.
Post-Traumatic Growth and How We Move Forward From COVID-19 | Blog
COVID-19 has changed the way we think, live, and work.
Leading Through Uncertainty Amidst the Global Pandemic | Perspectives
Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.
COVID-19 Vaccine Rollout: Lessons for Healthcare Comms | Blog
With about 700 million COVID-19 vaccine doses administered across the globe, the return to (relative) normalcy, in many parts of the world, is starting to feel closer and closer.
The Brand Imperative to Address HCP Burnout | Blog
With the devastating rise of the Delta variant, we’re now seeing news reminiscent of the early days of the pandemic: Hospitals are reaching capacity, with 1 in 5 ICUs having at least 95% of their beds filled.
The CDC’s Mask Guidance and the Importance of Consistent Messaging | Blog
The COVID-19 guidelines released by the Centers for Disease Control (CDC) in May, proclaiming that vaccinated people no longer needed to wear masks indoors, spurred widespread joy, seeming to herald the beginning of the end of times unprecedented.
Thriving in COVID-19 With Flexible Marketing Strategies | In The Media
Pharma sales is set to change forever.
Already have a RSS feed reader?